This week on H-Span, we are joined by Michael Ringel, PhD, Chief Operating Officer of Life Biosciences.
In this episode, we explore Michael's journey into the longevity space, the groundbreaking work happening at Life Biosciences, as well as their plans to launch human clinical trials for their epigenetic reprogramming asset within the next year.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
